Evaluation of the influence of genetic variants in Cereblon gene on the response to the treatment of erythema nodosum leprosum with thalidomide.

Authors:
Costa PDSS; Maciel-Fiuza MF; Kowalski TW; Fraga LR; Feira MF and 5 more

Journal:
Mem Inst Oswaldo Cruz

Publication Year: 2022

DOI:
10.1590/0074-02760220039

PMCID:
PMC9668341

PMID:
36383784

View on PubMed View on PMC View Publisher
Journal Information

Full Title: Mem Inst Oswaldo Cruz

Abbreviation: Mem Inst Oswaldo Cruz

Country: Unknown

Publisher: Unknown

Language: N/A

Publication Details

Subject Category: Tropical Medicine

Available in Europe PMC: Yes

Available in PMC: Yes

PDF Available: No

Related Papers from Same Journal
Different profiles of chemokines, cytokines and cell growth factors in plasma samples from patients…
de Carvalho JC; Pascoal-Xavier MA; Araújo MG and 5 more (2024) - Transparency Score: 2/6
Animal models and SARS-CoV-2-induced pulmonary and neurological injuries.
Pinto MA; da Silva ADS; Rodrigues DDRF and 5 more (2023) - Transparency Score: 2/6
An increased number of individuals of a potential host facilitates non-photic synchronisation in th…
Valentinuzzi/ VS; Abrahan LB. (2023) - Transparency Score: 2/6
Anxiety, depression, and memory loss in Chagas disease: a puzzle far beyond neuroinflammation to be…
Lannes-Vieira J; Vilar-Pereira G; Barrios LC and 1 more (2023) - Transparency Score: 2/6
A review of serological tests available in Brazil for intestinal schistosomiasis diagnosis.
Ramos LMDS; da Silva-Pereira RA; Oliveira E and 2 more (2023) - Transparency Score: 2/6
View All Papers from This Journal
Transparency Score
2/6
33.3% Transparent
Transparency Indicators
Click on green indicators to view evidence text
Core Indicators
Data Sharing
Code Sharing
COI Disclosure
Evidence found in paper:

"To the collaborators who helped in obtaining the specimens at all the participating centres, and the statistician Luciano Santos Pinto Guimarães, for his assistance with statistical analyses. FSLV is the recipient of a CNPq scholarship grant (no. 312960/2021-2). Financial support: INAGEMP (CNPq 573993/2008-4, 465549/2014-4, FAPERGS 17/2551.0000521-0 and CAPES), FIPE/HCPA (GPPG 10-0410) and CAPES. FSLV is recipient of a CNPq scholarship grant (312993/2017-0) and FSLV is recipient of a FAPERGS grant (19/2551-0001787-1)."

Protocol Registration
Open Access
Paper is freely available to read
Additional Indicators
Replication
Novelty Statement
Assessment Info

Tool: rtransparent

OST Version: N/A

Last Updated: Aug 05, 2025